Denali Capital Acquisition Corp. (DECA)
Delisted
9 Mar 2026
NASDAQ (NMS) NASDAQ (NMS) Primary $
11. 43
-0.38
-3.2176%
$
38.56M Market Cap
- P/E Ratio
- Div Yield
3,631 Volume
- Eps
$ 11.81
Previous Close Day Range
11.43 11.43
Year Range
5.09 13.2
Want to track DECA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln deal
Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company , will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion deal, the companies said on Tuesday.
Reuters | 1 year ago
Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital
Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public through a merger with special purpose acquisition company Denali Capital Acquisition Corp in a pre-transaction equity deal valued at up to $2 billion.
Reuters | 2 years ago
